Company Filing History:
4 out of 242 
3 out of 270 
Years Active: 2010-2021
Title: The Innovations of Hans Joerg Fehling
Introduction
Hans Joerg Fehling is a notable inventor based in Ulm, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for generating transgenic cell populations. With a total of 7 patents, his work has the potential to impact medical research and therapies.
Latest Patents
One of Fehling's latest patents is titled "Vector for targeting the human Rosa26 gene." This invention provides a method for generating a transgenic eukaryotic cell population with a modified human Rosa26 locus. The method includes introducing a functional DNA sequence into the human Rosa26 locus of starting eukaryotic cells. Additionally, the patent outlines targeting vectors useful in this method, as well as a cell population and a transgenic non-human animal comprising a modified human Rosa26 locus. It also provides an isolated DNA sequence corresponding to the human Rosa26 locus.
Another significant patent is the "Method of generating human pancreatic cells." This invention offers cell populations enriched for mesendoderm and mesoderm, as well as those enriched for endoderm. A selectable marker gene has been recombinantly targeted to the brachyury locus, allowing for the isolation and characterization of cell populations that comprise brachyury positive mesendoderm and mesoderm cells. These cell populations are particularly useful for generating cells for cell replacement therapy.
Career Highlights
Fehling has worked with prestigious institutions such as Mount Sinai School of Medicine and the Icahn School of Medicine at Mount Sinai. His research has focused on advancing the understanding of genetic modifications and their applications in medicine.
Collaborations
Some of his notable coworkers include Gordon Keller and Valerie Kouskoff. Their collaborative efforts have contributed to the advancements in the field of regenerative medicine.
Conclusion
Hans Joerg Fehling's innovative work in biotechnology and his numerous patents highlight his significant contributions to the field. His research continues to pave the way for advancements in medical therapies and genetic engineering.